Sign inJoin waitlistJoin the waitlist

Lois Ramondetta

Professor · University of Texas M D Anderson Cancer Center

Credentials: · · · · ·

History

University of Texas M D Anderson Cancer Center
Present

University of Texas M D Anderson Cancer Center
2000–2001
Gynecologic Oncology
University of Texas M D Anderson Cancer Center
1997–2000
Obstetrics and Gynecology
SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
1993–1997
Doctor of Medicine
1989–1993

Research

Improved survival with bevacizumab in advanced cervical cancer
New England Journal of Medicine · 2014 · 1,127 citations
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
The Lancet · 2017 · 530 citations
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study
Journal of Clinical Oncology · 2009 · 524 citations

Diane Bodurka
28 papers
Anuja Jhingran
24 papers
David Gershenson
23 papers
Jubilee Brown
21 papers · 5 as a fellow
Karen Lu
20 papers · 1 as a fellow
Kathleen Schmeler
17 papers
Pedro Ramirez
17 papers · 3 as a fellow
TB
Thomas Burke
17 papers
PE
Patricia Eifel
16 papers
Ann Klopp
14 papers · 2 as a fellow
Michael Frumovitz
14 papers
Pamela Soliman
14 papers · 2 as a resident

Grants

Efficacy of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation
National Cancer Institute · R01
PI · $678.5K · University of Tx Md Anderson Can Ctr
2026–2031

Clinical trials

Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer
Principal investigator · Recruiting
M.D. Anderson Cancer Center
2025–2027
Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer
Principal investigator · Active not recruiting
M.D. Anderson Cancer Center
2020–2027
Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)
Principal investigator · Terminated
M.D. Anderson Cancer Center
2013–2020
Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Principal investigator · Completed · Early phase 1
M.D. Anderson Cancer Center
2012–2019